Document is current
Any future updates will be listed below
-
Authors
Klotsman, Michael
Anderson, Wayne H.
Gilor, Chen
-
Funding
Funding for this research was provided by:
Okava Pharmaceuticals
- License Information
-
More Information
Article History
Received: 26 May 2023
Accepted: 2 May 2024
First Online: 18 May 2024
Declarations
:
: The study protocol was reviewed and approved by LFM Lab’s, an AAALAC accredited test facility, institutional animal care and use committee (IACUC) (protocol 22OKA038). This study was conducted under the standard operating procedures of LFM Labs, the AAALAC accredited testing facility, and was in compliance with current recommendations for the Guide for the Care and Use of Laboratory Animals. Consent to participate was not required for this study.
: Not applicable.
: MK and WHA are Okava Pharmaceuticals shareholders. CG is a consultant to Okava Pharmaceuticals.
